Alpha 2.0
Login Register
» Articles » PMID: 34102098

Outbreak of SARS-CoV-2 B.1.1.7 Lineage After Vaccination in Long-Term Care Facility, Germany, February-March 2021

Overview
Journal Emerg Infect Dis
Specialty Infectious Diseases
Date 2021 Jun 8
PMID 34102098
Citations 11
Authors
Pinkus Tober-Lau
Tatjana Schwarz
David Hillus
Jana Spieckermann
Elisa T Helbig
Lena J Lippert
Charlotte Thibeault
Willi Koch
Leon Bergfeld
Daniela Niemeyer
Barbara Muhlemann
Claudia Conrad
Stefanie Kasper
Friederike Munn
Frank Kunitz
Terry C Jones
Norbert Suttorp
Christian Drosten
Leif Erik Sander
Florian Kurth
Victor M Corman
Affiliations
Soon will be listed here.
Abstract

One week after second vaccinations were administered, an outbreak of B.1.1.7 lineage severe acute respiratory syndrome coronavirus 2 infections occurred in a long-term care facility in Berlin, Germany, affecting 16/20 vaccinated and 4/4 unvaccinated residents. Despite considerable viral loads, vaccinated residents experienced mild symptoms and faster time to negative test results.

Citing Articles

Epidemiology of COVID-19 outbreaks in aged care facilities during postvaccine period: a systematic review and meta-analysis.

Hashan M, Smoll N, Chapman G, King C, Walker J, Kirk M BMJ Open. 2024; 14(3):e073555.

PMID: 38485480 PMC: 10941149. DOI: 10.1136/bmjopen-2023-073555.

A Molecular and Epidemiological Investigation of a Large SARS-CoV-2 Outbreak in a Long-Term Care Facility in Luxembourg, 2021.

Ernst C, Pires-Afonso Y, Bejko D, Huberty C, Dentzer T, Wienecke-Baldacchino A Geriatrics (Basel). 2023; 8(1).

PMID: 36826361 PMC: 9957261. DOI: 10.3390/geriatrics8010019.

Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents.

Tuaillon E, Pisoni A, Veyrenche N, Rafasse S, Niel C, Gros N Sci Rep. 2022; 12(1):13749.

PMID: 35962053 PMC: 9373891. DOI: 10.1038/s41598-022-18041-x.

Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Hoteit R, Yassine H Vaccines (Basel). 2022; 10(6).

PMID: 35746526 PMC: 9230982. DOI: 10.3390/vaccines10060919.

Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review.

Gopinath S, Ishak A, Dhawan N, Poudel S, Shrestha P, Singh P Trop Med Infect Dis. 2022; 7(5).

PMID: 35622708 PMC: 9144541. DOI: 10.3390/tropicalmed7050081.

References
1.
Tenforde M, Olson S, Self W, Talbot H, Lindsell C, Steingrub J . Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(18):674-679. PMC: 9368749. DOI: 10.15585/mmwr.mm7018e1. View
2.
Gmehlin C, Munoz-Price L . Coronavirus disease 2019 (COVID-19) in long-term care facilities: A review of epidemiology, clinical presentations, and containment interventions. Infect Control Hosp Epidemiol. 2020; 43(4):504-509. PMC: 7684019. DOI: 10.1017/ice.2020.1292. View
3.
Thompson M, Burgess J, Naleway A, Tyner H, Yoon S, Meece J . Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December.... MMWR Morb Mortal Wkly Rep. 2021; 70(13):495-500. PMC: 8022879. DOI: 10.15585/mmwr.mm7013e3. View
4.
Muller L, Andree M, Moskorz W, Drexler I, Walotka L, Grothmann R . Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination. Clin Infect Dis. 2021; 73(11):2065-2072. PMC: 8135422. DOI: 10.1093/cid/ciab381. View
5.
Muik A, Wallisch A, Sanger B, Swanson K, Muhl J, Chen W . Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera. Science. 2021; 371(6534):1152-1153. PMC: 7971771. DOI: 10.1126/science.abg6105. View